Cognoptix
Boston, US · 1 known investors
Cognoptix develops the Sapphire II system, a non-invasive laser eye scanning device paired with an eye ointment that binds to beta amyloid proteins in the lens of the eye to aid early detection and diagnosis of Alzheimer's disease. The company builds diagnostic devices and agents for clinical, commercial, and academic research use and works with pharma partners and academic institutes.
Founders & leadership
DL
Dr. Lee GoldsteinCo-founder
DL
Dr. Leo ChylackCo-founder
SW
Susanne WilkeinPresident & CEO
CH
Carl H. SadowskyinChief Medical Officer
MK
Mike KaswanChief Financial Officer
PH
TT
Tom TrometerExecutive
GD
Gerald D. CagleExecutive
Board
GW
Gunnar WeikertBoard director
WS
Werner SchaeferBoard director
RG
Richard GillBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$13M disclosed across 2 rounds · 2014
▶$12.6MraisedOct 2014 · 32 investors · Other TechnologyRule 506(b)
▶$12.6MraisedOct 2014 · 32 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Christine de los ReyesDirector
- Tom TrometerExecutive Officer
- Paul HartungExecutive Officer, Director
- Gunnar WeikertDirector
- Offering amount
- $15.6M
- Amount sold
- $12.6M
- Sales commissions
- $405K
- Placement agents
- Robert W. Baird & Co. Incorporated
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$390KraisedApr 2014 · 22 investors · Other TechnologyRule 506(b)
▶$390KraisedApr 2014 · 22 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Paul HartungExecutive Officer, Director
- Gunnar WeikertDirector
- Tom TrometerExecutive Officer
- Gerald D. CagleExecutive Officer
- Werner SchaeferDirector
- Richard GillDirector
- Offering amount
- $1.5M
- Amount sold
- $390K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Cognoptix do?
- Cognoptix develops the Sapphire II system, a non-invasive laser eye scanning device paired with an eye ointment that binds to beta amyloid proteins in the lens of the eye to aid early detection and diagnosis of Alzheimer's disease. The company builds diagnostic devices and agents for clinical, commercial, and academic research use and works with pharma partners and academic institutes.
- Who founded Cognoptix?
- Cognoptix was founded by Dr. Lee Goldstein, Dr. Leo Chylack.
- Who are Cognoptix's investors?
- Cognoptix's investors include Boston Harbor Angels.
- How much funding has Cognoptix raised?
- Cognoptix has disclosed $13M raised across 2 rounds.
- Where is Cognoptix headquartered?
- Cognoptix is headquartered in Boston, US.